Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

How IRBs view and make decisions about coercion and undue influence.

Klitzman R.

J Med Ethics. 2013 Apr;39(4):224-9. doi: 10.1136/medethics-2011-100439. Epub 2012 Sep 14.

2.

US IRBs confronting research in the developing world.

Klitzman RL.

Dev World Bioeth. 2012 Aug;12(2):63-73. doi: 10.1111/j.1471-8847.2012.00324.x. Epub 2012 Apr 20.

3.

How IRBs make decisions: should we worry if they disagree?

Kaur S.

J Med Ethics. 2013 Apr;39(4):230. doi: 10.1136/medethics-2012-100965. Epub 2012 Oct 17. No abstract available.

PMID:
23077337
4.

How US institutional review boards decide when researchers need to translate studies.

Klitzman R.

J Med Ethics. 2014 Mar;40(3):193-7. doi: 10.1136/medethics-2012-101174. Epub 2013 Mar 8.

5.

How IRBs view and make decisions about consent forms.

Klitzman RL.

J Empir Res Hum Res Ethics. 2013 Feb;8(1):8-19. doi: 10.1525/jer.2013.8.1.8.

6.

How local IRBs view central IRBs in the US.

Klitzman R.

BMC Med Ethics. 2011 Jun 23;12:13. doi: 10.1186/1472-6939-12-13.

7.
8.

"Members of the same club": challenges and decisions faced by US IRBs in identifying and managing conflicts of interest.

Klitzman R.

PLoS One. 2011;6(7):e22796. doi: 10.1371/journal.pone.0022796. Epub 2011 Jul 29.

9.

Local IRBs vs. federal agencies: shifting dynamics, systems, and relationships.

Klitzman RL.

J Empir Res Hum Res Ethics. 2012 Jul;7(3):50-62. doi: 10.1525/jer.2012.7.3.50.

10.

Misconceptions about coercion and undue influence: reflections on the views of IRB members.

Largent E, Grady C, Miller FG, Wertheimer A.

Bioethics. 2013 Nov;27(9):500-7. doi: 10.1111/j.1467-8519.2012.01972.x. Epub 2012 Apr 12.

11.

How IRBs view and make decisions about social risks.

Klitzman RL.

J Empir Res Hum Res Ethics. 2013 Jul;8(3):58-65. doi: 10.1525/jer.2013.8.3.58.

12.

Undue inducement: nonsense on stilts?

Emanuel EJ.

Am J Bioeth. 2005 Sep-Oct;5(5):9-13; discussion W8-11, W17. No abstract available. Erratum in: Am J Bioeth. 2006 Jan-Feb;6(1):54.

PMID:
16179296
13.

Institutional review board community members: who are they, what do they do, and whom do they represent?

Klitzman R.

Acad Med. 2012 Jul;87(7):975-81. doi: 10.1097/ACM.0b013e3182578b54.

14.

Views and experiences of IRBs concerning research integrity.

Klitzman R.

J Law Med Ethics. 2011 Fall;39(3):513-28. doi: 10.1111/j.1748-720X.2011.00618.x.

15.

The ethics police?: IRBs' views concerning their power.

Klitzman R.

PLoS One. 2011;6(12):e28773. doi: 10.1371/journal.pone.0028773. Epub 2011 Dec 13.

16.

From anonymity to "open doors": IRB responses to tensions with researchers.

Klitzman R.

BMC Res Notes. 2012 Jul 3;5:347. doi: 10.1186/1756-0500-5-347.

17.

American Society of Clinical Oncology policy statement: oversight of clinical research.

American Society of Clinical Oncology.

J Clin Oncol. 2003 Jun 15;21(12):2377-86. Epub 2003 Apr 29.

PMID:
12721281
18.
19.

The welcome reassessment of research ethics: is "undue inducement" suspect?

Brody H.

Am J Bioeth. 2005 Sep-Oct;5(5):15-6. No abstract available.

PMID:
16179298

Supplemental Content

Support Center